Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 45.17 USD -0.68%
Market Cap: 2.2B USD
Have any thoughts about
Amphastar Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one AMPH stock under the Base Case scenario is 71.79 USD. Compared to the current market price of 45.17 USD, Amphastar Pharmaceuticals Inc is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AMPH Relative Value
Base Case
71.79 USD
Undervaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
17
vs Industry
39
Median 3Y
3.4
Median 5Y
2.9
Industry
2.6
Forward
2.9
vs History
79
vs Industry
33
Median 3Y
19
Median 5Y
19.3
Industry
23
Forward
11.2
vs History
69
vs Industry
35
Median 3Y
13.3
Median 5Y
14.5
Industry
17.8
vs History
57
vs Industry
35
Median 3Y
11.7
Median 5Y
12.4
Industry
25.4
vs History
15
vs Industry
27
Median 3Y
3.3
Median 5Y
2.7
Industry
2.2
vs History
11
vs Industry
34
Median 3Y
3.5
Median 5Y
2.8
Industry
2.8
Forward
3.4
vs History
19
vs Industry
33
Median 3Y
6.7
Median 5Y
6.3
Industry
5.4
vs History
82
vs Industry
36
Median 3Y
11.9
Median 5Y
14.3
Industry
13.7
Forward
8.2
vs History
76
vs Industry
36
Median 3Y
14.7
Median 5Y
17.8
Industry
17.2
Forward
9.4
vs History
49
vs Industry
34
Median 3Y
13.6
Median 5Y
14
Industry
16.5
vs History
68
vs Industry
25
Median 3Y
18
Median 5Y
19.1
Industry
19.3
vs History
30
vs Industry
39
Median 3Y
2.4
Median 5Y
2.1
Industry
2

Multiples Across Competitors

AMPH Competitors Multiples
Amphastar Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
2.2B USD 3.1 13.3 9.1 11.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6

See Also

Discover More
Back to Top